Global Venous Thromboembolism (VTE) Devices Market Research Report 2021

1 Venous Thromboembolism (VTE) Devices Market Overview

• 1.1 Product Overview and Scope of Venous Thromboembolism (VTE) Devices
• 1.2 Venous Thromboembolism (VTE) Devices Segment by Type
  • 1.2.1 Global Venous Thromboembolism (VTE) Devices Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Deep Vein Thrombosis(DVT)
  • 1.2.3 Pulmonary Embolism(PE)
  • 1.2.4 Others
• 1.3 Venous Thromboembolism (VTE) Devices Segment by Application
  • 1.3.1 Venous Thromboembolism (VTE) Devices Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Surgical Centers
  • 1.3.4 Other
• 1.4 Global Venous Thromboembolism (VTE) Devices Market Size Estimates and Forecasts
  • 1.4.1 Global Venous Thromboembolism (VTE) Devices Revenue 2016-2027
  • 1.4.2 Global Venous Thromboembolism (VTE) Devices Sales 2016-2027
  • 1.4.3 Venous Thromboembolism (VTE) Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Venous Thromboembolism (VTE) Devices Market Competition by Manufacturers

• 2.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Venous Thromboembolism (VTE) Devices Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Venous Thromboembolism (VTE) Devices Manufacturing Sites, Area Served, Product Type
• 2.5 Venous Thromboembolism (VTE) Devices Market Competitive Situation and Trends
  • 2.5.1 Venous Thromboembolism (VTE) Devices Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism (VTE) Devices Players Market Share by Revenue
  • 2.5.3 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Venous Thromboembolism (VTE) Devices Retrospective Market Scenario by Region

• 3.1 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
  • 3.3.1 North America Venous Thromboembolism (VTE) Devices Sales by Country
  • 3.3.2 North America Venous Thromboembolism (VTE) Devices Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
  • 3.4.1 Europe Venous Thromboembolism (VTE) Devices Sales by Country
  • 3.4.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Venous Thromboembolism (VTE) Devices Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region
  • 3.5.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
  • 3.6.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Country
  • 3.6.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country
  • 3.7.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Type

• 4.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2016-2021)
• 4.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2016-2021)
• 4.3 Global Venous Thromboembolism (VTE) Devices Price by Type (2016-2021)

5 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Application

• 5.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2016-2021)
• 5.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2016-2021)
• 5.3 Global Venous Thromboembolism (VTE) Devices Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 ArjoHuntleigh
  • 6.1.1 ArjoHuntleigh Corporation Information
  • 6.1.2 ArjoHuntleigh Description and Business Overview
  • 6.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 ArjoHuntleigh Product Portfolio
  • 6.1.5 ArjoHuntleigh Recent Developments/Updates
• 6.2 Armetheon
  • 6.2.1 Armetheon Corporation Information
  • 6.2.2 Armetheon Description and Business Overview
  • 6.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Armetheon Product Portfolio
  • 6.2.5 Armetheon Recent Developments/Updates
• 6.3 Bayer
  • 6.3.1 Bayer Corporation Information
  • 6.3.2 Bayer Description and Business Overview
  • 6.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bayer Product Portfolio
  • 6.3.5 Bayer Recent Developments/Updates
• 6.4 Bio Compression Systems
  • 6.4.1 Bio Compression Systems Corporation Information
  • 6.4.2 Bio Compression Systems Description and Business Overview
  • 6.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bio Compression Systems Product Portfolio
  • 6.4.5 Bio Compression Systems Recent Developments/Updates
• 6.5 Boehringer Ingelheim
  • 6.5.1 Boehringer Ingelheim Corporation Information
  • 6.5.2 Boehringer Ingelheim Description and Business Overview
  • 6.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Boehringer Ingelheim Product Portfolio
  • 6.5.5 Boehringer Ingelheim Recent Developments/Updates
• 6.6 Breg
  • 6.6.1 Breg Corporation Information
  • 6.6.2 Breg Description and Business Overview
  • 6.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Breg Product Portfolio
  • 6.6.5 Breg Recent Developments/Updates
• 6.7 Bristol-Myers Squibb
  • 6.6.1 Bristol-Myers Squibb Corporation Information
  • 6.6.2 Bristol-Myers Squibb Description and Business Overview
  • 6.6.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bristol-Myers Squibb Product Portfolio
  • 6.7.5 Bristol-Myers Squibb Recent Developments/Updates
• 6.8 Cardinal Health
  • 6.8.1 Cardinal Health Corporation Information
  • 6.8.2 Cardinal Health Description and Business Overview
  • 6.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cardinal Health Product Portfolio
  • 6.8.5 Cardinal Health Recent Developments/Updates
• 6.9 Currie Medical Specialties
  • 6.9.1 Currie Medical Specialties Corporation Information
  • 6.9.2 Currie Medical Specialties Description and Business Overview
  • 6.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Currie Medical Specialties Product Portfolio
  • 6.9.5 Currie Medical Specialties Recent Developments/Updates
• 6.10 Daiichi-Sankyo
  • 6.10.1 Daiichi-Sankyo Corporation Information
  • 6.10.2 Daiichi-Sankyo Description and Business Overview
  • 6.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Daiichi-Sankyo Product Portfolio
  • 6.10.5 Daiichi-Sankyo Recent Developments/Updates
• 6.11 Devon Medical Products
  • 6.11.1 Devon Medical Products Corporation Information
  • 6.11.2 Devon Medical Products Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Devon Medical Products Product Portfolio
  • 6.11.5 Devon Medical Products Recent Developments/Updates
• 6.12 DJO
  • 6.12.1 DJO Corporation Information
  • 6.12.2 DJO Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 DJO Product Portfolio
  • 6.12.5 DJO Recent Developments/Updates
• 6.13 Janssen
  • 6.13.1 Janssen Corporation Information
  • 6.13.2 Janssen Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Janssen Product Portfolio
  • 6.13.5 Janssen Recent Developments/Updates
• 6.14 Mego Afek AC LTD
  • 6.14.1 Mego Afek AC LTD Corporation Information
  • 6.14.2 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Mego Afek AC LTD Product Portfolio
  • 6.14.5 Mego Afek AC LTD Recent Developments/Updates
• 6.15 Normatec
  • 6.15.1 Normatec Corporation Information
  • 6.15.2 Normatec Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Normatec Product Portfolio
  • 6.15.5 Normatec Recent Developments/Updates
• 6.16 Pfizer
  • 6.16.1 Pfizer Corporation Information
  • 6.16.2 Pfizer Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Pfizer Product Portfolio
  • 6.16.5 Pfizer Recent Developments/Updates
• 6.17 Portola Pharmaceuticals
  • 6.17.1 Portola Pharmaceuticals Corporation Information
  • 6.17.2 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Portola Pharmaceuticals Product Portfolio
  • 6.17.5 Portola Pharmaceuticals Recent Developments/Updates
• 6.18 ThermoTek USA
  • 6.18.1 ThermoTek USA Corporation Information
  • 6.18.2 ThermoTek USA Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 ThermoTek USA Product Portfolio
  • 6.18.5 ThermoTek USA Recent Developments/Updates
• 6.19 Zimmer Biomet
  • 6.19.1 Zimmer Biomet Corporation Information
  • 6.19.2 Zimmer Biomet Venous Thromboembolism (VTE) Devices Description and Business Overview
  • 6.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Zimmer Biomet Product Portfolio
  • 6.19.5 Zimmer Biomet Recent Developments/Updates

7 Venous Thromboembolism (VTE) Devices Manufacturing Cost Analysis

• 7.1 Venous Thromboembolism (VTE) Devices Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
• 7.4 Venous Thromboembolism (VTE) Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Venous Thromboembolism (VTE) Devices Distributors List
• 8.3 Venous Thromboembolism (VTE) Devices Customers

9 Venous Thromboembolism (VTE) Devices Market Dynamics

• 9.1 Venous Thromboembolism (VTE) Devices Industry Trends
• 9.2 Venous Thromboembolism (VTE) Devices Growth Drivers
• 9.3 Venous Thromboembolism (VTE) Devices Market Challenges
• 9.4 Venous Thromboembolism (VTE) Devices Market Restraints

10 Global Market Forecast

• 10.1 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
• 10.2 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
• 10.3 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List